66
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease

, , , , , , , , , & show all
Pages 975-981 | Published online: 15 Sep 2014

References

  • World Health OrganizationThe global burden of disease: 2004 update2008
  • EidAAIonescuAANixonLSInflammatory response and body composition in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011648 Pt 11414141811704588
  • MostertRGorisAWeling-ScheepersCWoutersEFScholsAMTissue depletion and health related quality of life in patients with chronic obstructive pulmonary diseaseRespir Med200094985986711001077
  • HopkinsonNSTennantRCDayerMJA prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary diseaseRespir Res200782517355636
  • VestboJPrescottEAlmdalTBody mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart StudyAm J Respir Crit Care Med20061731798316368793
  • Di FranciaMBarbierDMegeJLOrehekJTumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19941505 Pt 1145314557952575
  • TakabatakeNNakamuraHAbeSThe relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20001614 Pt 11179118410764309
  • EaganTMAukrustPUelandTBody composition and plasma levels of inflammatory biomarkers in COPDEur Respir J20103651027103320413541
  • EaganTMGabazzaECD’Alessandro-GabazzaCTNF-α is associated with loss of lean body mass only in already cachectic COPD patientsRespir Res2012134822708547
  • BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
  • BafadhelMMcKennaSTerrySBlood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trialAm J Respir Crit Care Med20121861485522447964
  • RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
  • MillerMRCrapoRHankinsonJATS/ERS Task ForceGeneral considerations for lung function testingEur Respir J200526115316115994402
  • GuyattGMeasuring health status in chronic airflow limitationEur Respir J1988165605643049146
  • Health Protection AgencyInvestigation of bronchoalveolar lavage, sputum and associated specimensNational Standard Method BSOP2009572.3127
  • PizzichiniEPizzichiniMMEfthimiadisAIndices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurementsAm J Respir Crit Care Med19961542 Pt 13083178756799
  • PyeAStockleyRAHillSLSimple method for quantifying viable bacterial numbers in sputumJ Clin Pathol19954887197247560197
  • MillerAStraussBJMolSDual-energy X-ray absorptiometry is the method of choice to assess body composition in COPDRespirology200914341141819353776
  • SchutzYKyleUUPichardCFat-free mass index and fat mass index percentiles in Caucasians aged 18–98 yInt J Obes Relat Metab Disord200226795396012080449
  • World Health OrganisationPhysical status: The use and interpretation of anthropometryReport of a WHO expert committee19958541452
  • CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
  • LandboCPrescottELangePVestboJAlmdalTPPrognostic value of nutritional status in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199916061856186110588597
  • IschakiEPapatheodorouGGakiEPapaIKoulourisNLoukidesSBody mass and fat-free mass indices in COPD: relation with variables expressing disease severityChest2007132116416917505043
  • AgustíAEdwardsLDRennardSIEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsPersistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypePLoS One201275e3748322624038
  • IoanasMAngrillJBaldoXBronchial bacterial colonization in patients with resectable lung carcinomaEur Respir J200219232633211866014
  • ZhangQIllingRHuiCKBacteria in sputum of stable severe asthma and increased airway wall thicknessRespir Res2012133522513083
  • SindenNJStockleyRASystemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidenceThorax2010651093093620627907
  • ManWDKempPMoxhamJPolkeyMISkeletal muscle dysfunction in COPD: clinical and laboratory observationsClin Sci (Lond)2009117725126419681758
  • ManWDKempPMoxhamJPolkeyMIExercise and muscle dysfunction in COPD: implications for pulmonary rehabilitationClin Sci (Lond)2009117828129119689433
  • VermeerenMACreutzbergECScholsAMCOSMIC Study GroupPrevalence of nutritional depletion in a large out-patient population of patients with COPDRespir Med200610081349135516412624
  • ScholsAMBroekhuizenRWeling-ScheepersCAWoutersEFBody composition and mortality in chronic obstructive pulmonary diseaseAm J Clin Nutr2005821535916002800
  • WatzHWaschkiBBoehmeCClaussenMMeyerTMagnussenHExtrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional studyAm J Respir Crit Care Med2008177774375118048807
  • MenonMKHouchenLSinghSJMorganMDBraddingPSteinerMCInflammatory and satellite cells in the quadriceps of patients with COPD and response to resistance trainingChest201214251134114222459782
  • BarreiroEFerrerDSanchezFInflammatory cells and apoptosis in respiratory and limb muscles of patients with COPDJ Appl Physiol (1985)2011111380881721636562
  • BarreiroEScholsAMPolkeyMIENIGMA in COPD projectCytokine profile in quadriceps muscles of patients with severe COPDThorax200863210010717875568
  • CrulTSpruitMAGayan-RamirezGMarkers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patientsEur J Clin Invest2007371189790417883420
  • Montes de OcaMTorresSHDe SanctisJMataAHernándezNTálamoCSkeletal muscle inflammation and nitric oxide in patients with COPDEur Respir J200526339039716135718
  • DuncanBBSchmidtMIChamblessLEFolsomARCarpenterMHeissGFibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults – the ARIC study. Atherosclerosis Risk in CommunitiesObes Res20008427928610933303
  • DandonaPAljadaABandyopadhyayAInflammation: The link between insulin resistance, obesity and diabetesTrends Immunol20042514714698276
  • GakiEKontogianniKPapaioannouAIAssociations between BODE index and systemic inflammatory biomarkers in COPDCOPD20118640841322149400
  • PoulainMDoucetMDrapeauVMetabolic and inflammatory profile in obese patients with chronic obstructive pulmonary diseaseChron Respir Dis200851354118303100